NeoGenomics
NEO • NASDAQ
NeoGenomics is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Anthony Zook, with a market cap of $1.0B.
Market Cap$1.0B
Employees2.1K
CEOAnthony Zook
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Next EarningsApr 28, 2026 · In 2 weeksQ1 2026
Financials
NeoGenomics FAQ
Common questions about NeoGenomics
NeoGenomics is scheduled to report earnings for Q1 2026 on April 28, 2026. Analysts estimate revenue of $184.5M.
NeoGenomics has approximately 2,100 employees.